Astex Pharmaceuticals, Inc. (US)
John Lyons, a Senior Vice President at Astex Pharmaceuticals, has extensive experience in the pharmaceutical industry, with previous positions held at Astex Therapeutics, Supergen, Onyx Pharmaceuticals, and Cetus Corporation. John began their career as a scientist at Onyx Pharmaceuticals and has since progressed to senior leadership roles. John obtained a B Sc in Science from the University of Galway and completed their PhD at the University of Ulm.
This person is not in any offices
Astex Pharmaceuticals, Inc. (US)
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies. Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc. Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.